Kurzius updates McCormick (NYSE: MKC) 11.8% stake and 50,000-share sale

Rhea-AI Filing Summary

Lawrence E. Kurzius, Former Executive Chairman of McCormick & Company, filed Amendment No. 7 to his Schedule 13D reporting beneficial ownership of 1,944,120 shares of McCormick common stock, or 11.8% of the outstanding shares. This stake includes 1,569,277 shares that may be acquired within 60 days through vested stock options.

The filing confirms he has sole voting and dispositive power over all reported shares and no shared power. It also notes that on January 13, 2026 he exercised stock options to acquire 50,000 shares at an exercise price of $49.96 per share and then sold all 50,000 shares in an open-market transaction at $67.43 per share. Aside from this option exercise and sale, no other transactions in the past 60 days are reported.

Insights

Equity ownership and governance analyst

Kurzius updates his 11.8% McCormick stake and discloses a 50,000-share option exercise and sale.

The amendment shows Lawrence E. Kurzius continues to be a significant McCormick shareholder with 1,944,120 shares, representing 11.8% of the common stock. A large portion, 1,569,277 shares, comes from vested stock options exercisable within 60 days, indicating much of his exposure is tied to equity awards.

The filing highlights a specific recent transaction: on January 13, 2026 he exercised options for 50,000 shares at $49.96 and sold the same number at $67.43 in a brokered open-market trade. He retains sole voting and dispositive power over the reported position. This looks like a routine update to reflect ongoing equity award activity rather than a fundamental shift in ownership.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)

McCORMICK & COMPANY, INCORPORATED

(Name of Issuer)

Common Stock

(Title of Class of Securities)

579780206

(CUSIP Number)

Jeffery D. Schwartz
c/o McCormick & Company, Incorporated, 24 Schilling Road, Suite 1
Hunt Valley, MD, 21031
(410) 771-7301

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

01/13/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No. 579780206

1

Name of reporting person

Lawrence E. Kurzius

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF, OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 1,944,120.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 1,944,120.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

1,944,120.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

11.8 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

*See Item 5. **Based on (i) 14,851,729 shares of Common Stock outstanding as of December 31, 2025 plus (ii) 1,569,277 shares that may become issuable upon the exercise of stock options held by the Reporting Person.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock
(b)	Name of Issuer: McCORMICK & COMPANY, INCORPORATED
(c)	Address of Issuer's Principal Executive Offices: 24 Schilling Road, Suite 1, Hunt Valley, MARYLAND , 21031.
Item 2.	Identity and Background
(c)	The Reporting Person's present principal occupation is Former Executive Chairman of the Board of the Issuer. This Amendment No. 7 (the "Amendment") amends and supplements the Schedule 13D (the "Initial Schedule 13D") originally filed with the Securities and Exchange Commission (the "Commission") on January 29, 2020, by Lawrence E. Kurzius (the "Reporting Person"), as amended by Amendments No. 1, No. 2, No. 3, No. 4, No. 5, and No. 6 to Schedule 13D filed with the Commission on February 10, 2021, February 16, 2022, and February 10, 2023, April 19, 2023, January 11, 2024 and January 29, 2025, respectively. Capitalized terms used but not otherwise defined in this Amendment shall have the meanings ascribed to such terms in the Schedule 13D. Except as otherwise provided herein, each Item of the Schedule 13D remains unchanged.
Item 5.	Interest in Securities of the Issuer
(a)	As of the date hereof, the Reporting Person beneficially owns, in aggregate, 1,944,120 shares of Common Stock, representing 11.8% of the Issuer's outstanding shares of Common Stock. The Reporting Person's beneficial ownership includes 1,569,277 shares of Common Stock that may be acquired within 60 days of the date hereof pursuant to the exercise of vested stock options.
(b)	(i) Sole power to vote or direct the vote: 1,944,120 (ii) Shared power to vote or direct the vote: -0- (iii) Sole power to dispose or direct the disposition: 1,944,120 (iv) Shared power to dispose or direct the disposition: -0-
(c)	The Reporting Person has effected no transactions in the Common Stock within the past sixty days, except as previously reported on Forms 4 filed with the Commission as follows: on January 13, 2026, the Reporting Person exercised previously granted stock options to acquire 50,000 shares of Common Stock at an exercise price of $49.96 per share and subsequently sold all such shares in an open market transaction through a broker at a price of $67.43 per share.
Item 7.	Material to be Filed as Exhibits.
	99.1 Power of Attorney (incorporated by reference to Exhibit 24 to the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 4, 2025).

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lawrence E. Kurzius

Signature:	/s/ Jason E. Wynn
Name/Title:	Attorney-in-Fact
Date:	01/15/2026

FAQ

What ownership stake in McCormick (MKC) does Lawrence E. Kurzius report in this Schedule 13D/A?

He reports beneficial ownership of 1,944,120 shares of McCormick common stock, representing 11.8% of the outstanding shares of the company.

How many McCormick (MKC) shares underlying stock options are included in Kurzius’s reported holdings?

His reported beneficial ownership includes 1,569,277 shares of McCormick common stock that may be acquired within 60 days through the exercise of vested stock options.

Did Lawrence E. Kurzius recently buy or sell McCormick (MKC) shares?

Yes. On January 13, 2026, he exercised stock options to acquire 50,000 shares of McCormick common stock at $49.96 per share and sold all 50,000 shares in an open-market transaction at $67.43 per share.

What voting and dispositive power does Kurzius report over his McCormick (MKC) shares?

He reports sole voting power and sole dispositive power over 1,944,120 shares, with no shared voting or dispositive power.

What is the total McCormick (MKC) share count used to calculate Kurzius’s 11.8% ownership?

The 11.8% figure is based on 14,851,729 shares of common stock outstanding as of December 31, 2025 plus 1,569,277 shares that may become issuable upon the exercise of stock options he holds.

What is Lawrence E. Kurzius’s role in relation to McCormick (MKC)?

He is identified as the Former Executive Chairman of the Board of McCormick & Company, Incorporated.